Full Text
EE268 Cost-Effectiveness Analysis of Mirvetuximab Soravtansine in FRa-Positive Platinum-Resistant Ovarian Cancer in Japan

Abstract

Authors

Kano Miki Kensuke Moriwaki Kosuke MORIMOTO Munenobu Kashiwa Kojiro Shimozuma

Back to Volume 28, Supplemental Issue 6S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×